Skip to main content
Hit enter to search or ESC to close
Close Search
ADx Neurosciences - State-of-the-art biomarker assaysADx Neurosciences - State-of-the-art biomarker assays
search
Menu
  • Home
  • Pharma Solutions
  • IVD Solutions
  • Portfolio
  • About Us
    • Board of directors
    • Management team
  • News and Media
  • Upcoming events
  • Contact
  • search
Category

Tau

Categories

  • Synapses
  • Synuclein
  • Tau
  • Amyloid
  • News
  • Publications
  • Events

Recent Posts

  • ADx NeuroSciences’ review of 2021
  • ADx will be present at the upcoming virtual AAIC 2020
  • ADx presents at ADPD results on VAMP2, a new synaptic biomarker showing significant changes in very early pre-clinical disease state.
  • Present at CTAD 2019
  • ADx receives funding from Bill Gates for developing blood biomarkers

Archives

  • January 2022
  • December 2020
  • July 2020
  • April 2020
  • December 2019
  • December 2018
[contact-form-7 404 "Not Found"]

Our Company

ADx NeuroSciences NV
Technologiepark 94
9052 Gent

BTW: 0839.400.980

Navigation

  • Home
  • Pharma Solutions
  • IVD Solutions
  • Portfolio
  • About Us
  • News and Media
  • Contact

Information

  • Privacy Statement
  • Cookie policy
  • Exercise form
  • General Terms & Conditions of Sale

Credits

Website by Turnstone

Close Menu
  • Home
  • Pharma Solutions
  • IVD Solutions
  • Portfolio
  • About Us
    • Board of directors
    • Management team
  • News and Media
  • Upcoming events
  • Contact